{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Cognitive Behavioral Therapy for Symptom Management in Treatment-Resistant Schizophrenia

Activity Steps

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Recognize the background information the authors explored when planning their integrative review of the efficacy of CBT as an adjunctive approach to for TRS.
  2. Select the results of the authors? review that could lend insight to health care professionals about using CBT as an adjunctive approach to TRS.
  3. Choose the appropriate intervention when working with patients who have TRS.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of an integrative review conducted to assess the efficacy of cognitive behavioral therapy (CBT) as an adjunctive approach to treatment-resistant schizophrenia (TRS) in various study populations by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $21.95


  • ANCC 2.0 CH
  • DC - BON 2.0 CH
  • FL - BON 2.0 CH
  • GA - BON 2.0 CH
  • NM - BON 2.0 CH
  • SC - BON 2.0 CH
  • WV - BOERN 2.0 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

Test Code: AJN0822
Published: August 2022
Expires: 6/6/2025
Required Passing Score: 8/10 (80%)
Authors: Matilda Ryan, MSN, FNP, PMHNP; Dina Sattenspiel, MSN, PMHNP; Alexander Chianese, MSN, PMHNP; Helen Rice, MSN, PMHNP